Gender Comparison of Efficacy and Safety of Ranolazine for Chronic Angina Pectoris in Four Randomized Clinical Trials
- 1 January 2007
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 99 (1), 11-18
- https://doi.org/10.1016/j.amjcard.2006.07.052
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Antianginal Efficacy of Ranolazine When Added to Treatment With Amlodipine: The ERICA (Efficacy of Ranolazine in Chronic Angina) TrialJournal of the American College of Cardiology, 2006
- Incidence and Prognostic Implications of Stable Angina Pectoris Among Women and MenJAMA, 2006
- Gender Differences in the Management and Clinical Outcome of Stable AnginaCirculation, 2006
- Comparative efficacy of ranolazine versus atenolol for chronic angina pectorisThe American Journal of Cardiology, 2005
- Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaJournal of the American College of Cardiology, 2004
- Effects of Ranolazine With Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients With Severe Chronic AnginaA Randomized Controlled TrialJama-Journal Of The American Medical Association, 2004
- Coronary heart disease: the female heart is vulnerableProgress in Cardiovascular Diseases, 2003
- Sex differences in chest pain in patients with documented coronary artery disease and exercise-induced ischemia: Results from the PIMI studyAmerican Heart Journal, 2001
- Development and evaluation of the Seattle Angina questionnaire: A new functional status measure for coronary artery diseaseJournal of the American College of Cardiology, 1995
- Characteristics of a contemporary population with angina pectorisThe American Journal of Cardiology, 1994